Paul Levy, CEO, Beth Israel Deaconess, on transparency in the medical center setting
Paul Levy, CEO of Beth Israel Deaconess (BID) medical center, discusses transparency at BID and across the health sector. He describes the resistance he initially faced when BID began publishing its clinical results, and then argues that the major value of transparency in the health sector is to help the industry get a better view of itself, thereby learning how to give better care to patients.
Particularly for an academic medical center such as BID, Levy explains, transparency around clinical results, balanced with respect for patient privacy, should be a strong part of its mission. In fact, more data within the industry should be made public, he argues.
- The Health Sector MBA Curriculum
- Health Sector Management Degrees at the School of Management
- The Transparency Tipping Point: Business trends, care implications, and innovation in the health sector
- Jerry Steinberg, Senior Medical Director and Chief Quality Officer, Cambridge Health Alliance
- Allison Lawton, SVP, Genzyme, on the major drivers of transparency in the pharmaceutical industry
- Roberta Clarke on deception, transparency, and the responsibility of the medical consumer